Bethesda, MD

CEO, Connect4Strategies

Represented: Policy Makers
Term ended August 2022

Saira Sultan, JD, has been at the nexus of patient groups, the medical community, drug/device manufacturers, and governmental organizations, for more than two decades. Her passion for rare and ultrarare disease issues culminated in her founding of the Haystack Project in 2016. Through Haystack, Sultan has given voice to the experiences and perspectives of patients with rare and ultrarare conditions to influence research and policy making.

She also continues to work with patient groups suffering from more common conditions such as cancer, sickle cell disease, pain, and addiction. Her history with the cancer community stretches back nearly 20 years to when she directed government affairs for the Association of Community Cancer Centers. During her career, she also held leadership positions with Pfizer, Sanofi, and Medtronic.

Sultan holds a juris doctor from the University of Virginia in Charlottesville, Virginia.

Sultan served on the Advisory Panel on Rare Disease from August 2019 to August 2022.

Conflicts of Interest

As of March 29, 2019

  • Connect 4 Strategies, President/CEO
  • PTEN, Board Member
  • The Haystack Project, Founder


Person Type
Panel / Committee